{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:05:52Z","timestamp":1791198352090,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,10,19]]},"DOI":"10.1038\/onc.2017.171","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T15:02:57Z","timestamp":1497884577000},"page":"5840-5851","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis"],"prefix":"10.1038","volume":"36","author":[{"given":"Y","family":"Klymenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lombard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Alber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M S","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"BFonc2017171_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A . Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2017171_CR2","first-page":"19","volume-title":"SEER Cancer Statistics Review, 1975\u20132008","author":"N Howlader","year":"2011","unstructured":"Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W et al. SEER Cancer Statistics Review, 1975\u20132008. National Cancer Institute: Bethesda, MD, USA, 2011. p 19."},{"key":"BFonc2017171_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/jca.7810","volume":"5","author":"CS Marcus","year":"2014","unstructured":"Marcus CS, Maxwell GL, Darcy KM, Hamilton CA, McGuire WP . Current approaches and challenges in managing and monitoring treatment response in ovarian cancer. J Cancer 2014; 5: 25.","journal-title":"J Cancer"},{"key":"BFonc2017171_CR4","first-page":"255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AST, Choi K, Kang SK, Leung PCK . Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255\u2013288.","journal-title":"Endocr Rev"},{"key":"BFonc2017171_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","volume":"25","author":"LG Hudson","year":"2008","unstructured":"Hudson LG, Zeineldin R, Stack MS . Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 2008; 25: 643\u2013655.","journal-title":"Clin Exp Metastasis"},{"key":"BFonc2017171_CR6","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R . New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2008; 26: 5284\u20135293.","journal-title":"J Clin Oncol"},{"key":"BFonc2017171_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E . Ovarian cancer development and metastasis. Am J Pathol 2010; 177: 1053\u20131064.","journal-title":"Am J Pathol"},{"key":"BFonc2017171_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, Nishimura M, Chaluvally-Raghavan P, Miyake T et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell 2014; 26: 77\u201391.","journal-title":"Cancer Cell"},{"key":"BFonc2017171_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","volume":"175","author":"LG Coffman","year":"2016","unstructured":"Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ . New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Transl Res 2016; 175: 92\u2013102.e2.","journal-title":"Transl Res"},{"key":"BFonc2017171_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0014-4827(85)90197-1","volume":"160","author":"MJ Niedbala","year":"1985","unstructured":"Niedbala MJ, Crickard K, Bernacki RJ . Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix: an in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res 1985; 160: 499\u2013513.","journal-title":"Exp Cell Res"},{"key":"BFonc2017171_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","volume":"1","author":"MP Iwanicki","year":"2011","unstructured":"Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov 2011; 1: 144\u2013157.","journal-title":"Cancer Discov"},{"key":"BFonc2017171_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","volume":"93","author":"KM Burleson","year":"2004","unstructured":"Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema Jr TR, Skubitz APN . Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 2004; 93: 170\u2013181.","journal-title":"Gynecol Oncol"},{"key":"BFonc2017171_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1479-5876-4-6","volume":"4","author":"KM Burleson","year":"2006","unstructured":"Burleson KM, Boente MP, Pambuccian SE, Skubitz AP . Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med 2006; 4: 6.","journal-title":"J Transl Med"},{"key":"BFonc2017171_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bpj.2015.07.025","volume":"109","author":"LA Lautscham","year":"2015","unstructured":"Lautscham LA, K\u00e4mmerer C, Lange JR, Kolb T, Mark C, Schilling A et al. Migration in confined 3D environments is determined by a combination of adhesiveness, nuclear volume, contractility, and cell stiffness. Biophys J 2015; 109: 900\u2013913.","journal-title":"Biophys J"},{"key":"BFonc2017171_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ncb1616","volume":"9","author":"K Wolf","year":"2007","unstructured":"Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007; 9: 893\u2013904.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017171_CR16","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1158\/0008-5472.CAN-08-0784","volume":"68","author":"P Friedl","year":"2008","unstructured":"Friedl P, Wolf K . Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 2008; 68: 7247\u20137249.","journal-title":"Cancer Res"},{"key":"BFonc2017171_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0092-8674(03)00513-0","volume":"114","author":"KB Hotary","year":"2003","unstructured":"Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ . Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003; 114: 33\u201345.","journal-title":"Cell"},{"key":"BFonc2017171_CR18","doi-asserted-by":"publisher","first-page":"24833","DOI":"10.1074\/jbc.M005631200","volume":"276","author":"SM Ellerbroek","year":"2001","unstructured":"Ellerbroek SM, Wu YI, Overall CM, Stack MS . Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001; 276: 24833\u201324842.","journal-title":"J Biol Chem"},{"key":"BFonc2017171_CR19","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1074\/jbc.M608428200","volume":"282","author":"MV Barbolina","year":"2007","unstructured":"Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS . Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J Biol Chem 2007; 282: 4924\u20134931.","journal-title":"J Biol Chem"},{"key":"BFonc2017171_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.bjc.6603863","volume":"97","author":"K Sodek","year":"2007","unstructured":"Sodek K, Ringuette M, Brown T . MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells. Br J Cancer 2007; 97: 358\u2013367.","journal-title":"Br J Cancer"},{"key":"BFonc2017171_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King SM, Hilliard TS, Wu LY, Jaffe RC, Fazleabas AT, Burdette JE . The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr Relat Cancer 2011; 18: 627\u2013642.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2017171_CR22","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.fertnstert.2010.04.055","volume":"94","author":"C Poncelet","year":"2010","unstructured":"Poncelet C, Cornelis F, Tepper M, Sauce E, Magan N, Wolf JP et al. Expression of E-and N-cadherin and CD44 in endometrium and hydrosalpinges from infertile women. Fertil Steril 2010; 94: 2909\u20132912.","journal-title":"Fertil Steril"},{"key":"BFonc2017171_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jcp.21240","volume":"213","author":"N Ahmed","year":"2007","unstructured":"Ahmed N, Thompson EW, Quinn MA . Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 2007; 213: 581\u2013588.","journal-title":"J Cell Physiol"},{"issue":"7","key":"BFonc2017171_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neo.2017.04.002","volume":"19","author":"Yuliya Klymenko","year":"2017","unstructured":"Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E et al. Heterogeneous cadherin expression and multi-cellular aggregate dynamics in ovarian cancer dissemination. Neoplasia 2017; DOI:10.1016\/j.neo.2017.04.002.","journal-title":"Neoplasia"},{"key":"BFonc2017171_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ncb2548","volume":"14","author":"P Friedl","year":"2012","unstructured":"Friedl P, Locker J, Sahai E, Segall JE . Classifying collective cancer cell invasion. Nat Cell Biol 2012; 14: 777\u2013783.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017171_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrm2720","volume":"10","author":"P Friedl","year":"2009","unstructured":"Friedl P, Gilmour D . Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445\u2013457.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Pt 13","key":"BFonc2017171_CR27","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1242\/jcs.086231","volume":"124","author":"ET Roussos","year":"2011","unstructured":"Roussos ET, Balsamo M, Alford SK, Wyckoff JB, Gligorijevic B, Wang Y et al. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J Cell Sci 2011; 124 (Pt 13): 2120\u20132131.","journal-title":"J Cell Sci"},{"key":"BFonc2017171_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1309\/B1YX-L8DB-TGY1-7905","volume":"115","author":"B Davidson","year":"2001","unstructured":"Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M et al. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Am J Clin Pathol 2001; 115: 517\u2013524.","journal-title":"Am J Clin Pathol"},{"key":"BFonc2017171_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0303-7207(01)00709-2","volume":"187","author":"B Davidson","year":"2002","unstructured":"Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM et al. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 2002; 187: 39\u201345.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2017171_CR30","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","volume":"69","author":"NM Moss","year":"2009","unstructured":"Moss NM, Barbolina MV, Liu Y, Sun L, Munshi HG, Stack MS . Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Res 2009; 69: 7121\u20137129.","journal-title":"Cancer Res"},{"issue":"Pt 7","key":"BFonc2017171_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1242\/jcs.028183","volume":"122","author":"RA Desai","year":"2009","unstructured":"Desai RA, Gao L, Raghavan S, Liu WF, Chen CS . Cell polarity triggered by cell-cell adhesion via E-cadherin. J Cell Sci 2009; 122 (Pt 7): 905\u2013911.","journal-title":"J Cell Sci"},{"key":"BFonc2017171_CR32","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1242\/jcs.103861","volume":"125","author":"W Shih","year":"2012","unstructured":"Shih W, Yamada S . N-cadherin-mediated cell\u2013cell adhesion promotes cell migration in a three-dimensional matrix. J Cell Sci 2012; 125: 3661\u20133670.","journal-title":"J Cell Sci"},{"key":"BFonc2017171_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/ncb1658","volume":"9","author":"C Gaggioli","year":"2007","unstructured":"Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9: 1392\u20131400.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017171_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10585-013-9565-x","volume":"30","author":"SP Carey","year":"2013","unstructured":"Carey SP, Starchenko A, McGregor AL, Reinhart-King CA . Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model. Clin Exp Metastasis 2013; 30: 615\u2013630.","journal-title":"Clin Exp Metastasis"},{"key":"BFonc2017171_CR35","first-page":"e3888","volume":"17","author":"RA Davidowitz","year":"2012","unstructured":"Davidowitz RA, Iwanicki MP, Brugge JS . In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. J Vis Exp 2012; 17: e3888.","journal-title":"J Vis Exp"},{"key":"BFonc2017171_CR36","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel E, Burdette J, Kenny H, Matei D, Pilrose J, Haluska P et al. Epithelial ovarian cancer experimental models. Oncogene 2014; 33: 3619\u20133633.","journal-title":"Oncogene"},{"key":"BFonc2017171_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1387\/ijdb.041821pf","volume":"48","author":"P Friedl","year":"2004","unstructured":"Friedl P, Hegerfeldt Y, Tusch M . Collective cell migration in morphogenesis and cancer. Int J Dev Biol 2004; 48: 441\u2013450.","journal-title":"Int J Dev Biol"},{"key":"BFonc2017171_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ceb.2003.11.001","volume":"16","author":"P Friedl","year":"2004","unstructured":"Friedl P . Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 2004; 16: 14\u201323.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2017171_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.cell.2011.11.016","volume":"147","author":"P Friedl","year":"2011","unstructured":"Friedl P, Alexander S . Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147: 992\u20131009.","journal-title":"Cell"},{"key":"BFonc2017171_CR40","first-page":"2125","volume":"62","author":"Y Hegerfeldt","year":"2002","unstructured":"Hegerfeldt Y, Tusch M, Brocker EB, Friedl P . Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. Cancer Res 2002; 62: 2125\u20132130.","journal-title":"Cancer Res"},{"issue":"Pt 18","key":"BFonc2017171_CR41","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1242\/jcs.036525","volume":"122","author":"O Ilina","year":"2009","unstructured":"Ilina O, Friedl P . Mechanisms of collective cell migration at a glance. J Cell Sci 2009; 122 (Pt 18): 3203\u20133208.","journal-title":"J Cell Sci"},{"key":"BFonc2017171_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07231.x","volume":"154","author":"K Wolf","year":"2006","unstructured":"Wolf K, Friedl P . Molecular mechanisms of cancer cell invasion and plasticity. Br J Dermatol 2006; 154 Suppl 1: 11\u20135.","journal-title":"Br J Dermatol"},{"key":"BFonc2017171_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jso.2930310109","volume":"31","author":"C Bell","year":"1986","unstructured":"Bell C, Stadler J, Waizbard E, Chaitchik S, Greif F . Tumor differentiation and histological type in human breast cancer. J Surg Oncol 1986; 31: 39\u201343.","journal-title":"J Surg Oncol"},{"key":"BFonc2017171_CR44","unstructured":"Page DL, Anderson TJ Diagnostic Histopathology of the Breast. Churchill Livingstone, Edinburgh, 1987."},{"key":"BFonc2017171_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00000372-198402000-00014","volume":"6","author":"AB Ackerman","year":"1984","unstructured":"Ackerman AB, Godomski J . Neurotropic malignant melanoma and other neurotropic neoplasms in the skin. Am J Dermatopathol 1984; 6: 63\u201380.","journal-title":"Am J Dermatopathol"},{"key":"BFonc2017171_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/00000658-198107000-00019","volume":"194","author":"CL Day Jr","year":"1981","unstructured":"Day CL Jr, Harrist TJ, Gorstein F, Sober AJ, Lew RA, Friedman RJ et al. Malignant melanoma. Prognostic significance of \u201cmicroscopic satellites\u201d in the reticular dermis and subcutaneous fat. Ann Surg 1981; 194: 108\u2013112.","journal-title":"Ann Surg"},{"key":"BFonc2017171_CR47","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/cncr.21533","volume":"104","author":"N Takai","year":"2005","unstructured":"Takai N, Jain A, Kawamata N, Popoviciu LM, Said JW, Whittaker S et al. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth. Cancer 2005; 104: 2701\u20132708.","journal-title":"Cancer"},{"key":"BFonc2017171_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","volume":"10","author":"TJ Shaw","year":"2004","unstructured":"Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC . Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther 2004; 10: 1032\u20131042.","journal-title":"Mol Ther"},{"key":"BFonc2017171_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0046-8177(98)90226-X","volume":"29","author":"S Afzal","year":"1998","unstructured":"Afzal S, Lalani E, Poulsom R, Stubbs A, Rowlinson G, Sato H et al. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998; 29: 155\u2013165.","journal-title":"Hum Pathol"},{"key":"BFonc2017171_CR50","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1158\/0008-5472.CAN-15-0706","volume":"75","author":"Y Liu","year":"2015","unstructured":"Liu Y, Metzinger MN, Lewellen KA, Cripps SN, Carey KD, Harper EI et al. Obesity contributes to ovarian cancer metastatic success through increased lipogenesis, enhanced vascularity, and decreased infiltration of M1 macrophages. Cancer Res 2015; 75: 5046\u20135057.","journal-title":"Cancer Res"},{"key":"BFonc2017171_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","volume":"138","author":"AK Mitra","year":"2015","unstructured":"Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J et al. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecol Oncol 2015; 138: 372\u2013377.","journal-title":"Gynecol Oncol"},{"key":"BFonc2017171_CR52","doi-asserted-by":"publisher","first-page":"14580","DOI":"10.1038\/srep14580","volume":"5","author":"SI Fraley","year":"2015","unstructured":"Fraley SI, Wu PH, He L, Feng Y, Krisnamurthy R, Longmore GD et al. Three-dimensional matrix fiber alignment modulates cell migration and MT1-MMP utility by spatially and temporally directing protrusions. Sci Rep 2015; 5: 14580.","journal-title":"Sci Rep"},{"key":"BFonc2017171_CR53","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1172\/JCI69815","volume":"124","author":"RA Davidowitz","year":"2014","unstructured":"Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H et al. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J Clin Invest 2014; 124: 2611\u20132625.","journal-title":"J Clin Invest"},{"key":"BFonc2017171_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.0.CO;2-4","volume":"67","author":"TL Moser","year":"1996","unstructured":"Moser TL, Pizzo SV, Bafetti LM, Fishman DA, Stack MS . Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the \u03b1A2\u03b21 integrin. Int J Cancer 1996; 67: 695\u2013701.","journal-title":"Int J Cancer"},{"key":"BFonc2017171_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell 2013; 154: 1047\u20131059.","journal-title":"Cell"},{"key":"BFonc2017171_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M et al. Role of YAP\/TAZ in mechanotransduction. Nature 2011; 474: 179\u2013183.","journal-title":"Nature"},{"key":"BFonc2017171_CR57","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/nmat4725","volume":"15","author":"BD Cosgrove","year":"2016","unstructured":"Cosgrove BD, Mui KL, Driscoll TP, Caliari SR, Mehta KD, Assoian RK et al. N-cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cells. Nat Mater 2016; 15: 1297\u20131306.","journal-title":"Nat Mater"},{"key":"BFonc2017171_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cub.2014.11.043","volume":"25","author":"AM Pasapera","year":"2015","unstructured":"Pasapera AM, Plotnikov SV, Fischer RS, Case LB, Egelhoff TT, Waterman CM . Rac1-dependent phosphorylation and focal adhesion recruitment of myosin IIA regulates migration and mechanosensing. Curr Biol 2015; 25: 175\u2013186.","journal-title":"Curr Biol"},{"key":"BFonc2017171_CR59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie A, Kato T, Brugu\u00e9s A, Serra-Picamal X, Derzsi S, Arwert E et al. A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol 2017; 19: 224\u2013237.","journal-title":"Nat Cell Biol"},{"key":"BFonc2017171_CR60","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1046\/j.1471-4159.2001.00140.x","volume":"76","author":"MA Utton","year":"2001","unstructured":"Utton MA, Eickholt B, Howell FV, Wallis J, Doherty P . Soluble N\u2010cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N\u2010cadherin and the fibroblast growth factor receptor co\u2010cluster in cells. J Neurochem 2001; 76: 1421\u20131430.","journal-title":"J Neurochem"},{"key":"BFonc2017171_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/7542","volume":"6","author":"H Takeda","year":"1999","unstructured":"Takeda H, Shimoyama Y, Nagafuchi A, Hirohashi S . E-cadherin functions as a cis-dimer at the cell\u2013cell adhesive interface in vivo. Nat Struct Biol 1999; 6: 310\u2013312.","journal-title":"Nat Struct Biol"},{"key":"BFonc2017171_CR62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.147.3.631","volume":"147","author":"MT Nieman","year":"1999","unstructured":"Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ . N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 631\u2013644.","journal-title":"J Cell Biol"},{"key":"BFonc2017171_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/mcne.1996.0049","volume":"8","author":"P Doherty","year":"1996","unstructured":"Doherty P, Walsh FS . CAM-FGF receptor interactions: a model for axonal growth. Mol Cell Neurosci 1996; 8: 99\u2013111.","journal-title":"Mol Cell Neurosci"},{"key":"BFonc2017171_CR64","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1517\/13543784.16.4.451","volume":"16","author":"A Mariotti","year":"2007","unstructured":"Mariotti A, Perotti A, Sessa C, R\u00fcegg C . N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs 2007; 16: 451\u2013465.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFonc2017171_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejphar.2009.05.033","volume":"625","author":"OW Blaschuk","year":"2009","unstructured":"Blaschuk OW, Devemy E . Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 2009; 625: 195\u2013198.","journal-title":"Eur J Pharmacol"},{"key":"BFonc2017171_CR66","doi-asserted-by":"publisher","first-page":"20140039","DOI":"10.1098\/rstb.2014.0039","volume":"370","author":"OW Blaschuk","year":"2015","unstructured":"Blaschuk OW . N-cadherin antagonists as oncology therapeutics. Philos Trans R Soc Lond B Biol Sci 2015; 370: 20140039.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFonc2017171_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ijc.23027","volume":"122","author":"Y Shintani","year":"2008","unstructured":"Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ et al. ADH\u20101 suppresses N\u2010cadherin\u2010dependent pancreatic cancer progression. Int J Cancer 2008; 122: 71\u201377.","journal-title":"Int J Cancer"},{"key":"BFonc2017171_CR68","first-page":"271","volume":"3","author":"NM Sadler","year":"2013","unstructured":"Sadler NM, Harris BR, Metzger BA, Kirshner J . N-cadherin impedes proliferation of the multiple myeloma cancer stem cells. Am J Blood Res 2013; 3: 271\u2013285.","journal-title":"Am J Blood Res"},{"key":"BFonc2017171_CR69","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1158\/0008-5472.CAN-07-5949","volume":"68","author":"CK Augustine","year":"2008","unstructured":"Augustine CK, Yoshimoto Y, Gupta M, Zipfel PA, Selim MA, Febbo P et al. Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 2008; 68: 3777\u20133784.","journal-title":"Cancer Res"},{"issue":"suppl-18","key":"BFonc2017171_CR70","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/jco.2006.24.18_suppl.3016","volume":"24","author":"DJ Stewart","year":"2006","unstructured":"Stewart DJ, Jonker DJ, Goel R, Goss G, Maroun JA, Cripps CM et al. Final clinical and pharmacokinetic (PK) results from a phase 1 study of the novel N-cadherin (N-cad) antagonist, Exherin (ADH-1), in patients with refractory solid tumors stratified according to N-cad expression. Pet J Clin Oncol 2006; 24 (suppl-18): 3016\u201330160.","journal-title":"Pet J Clin Oncol"},{"key":"BFonc2017171_CR71","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.peptides.2008.06.025","volume":"29","author":"E Devemy","year":"2008","unstructured":"Devemy E, Blaschuk OW . Identification of a novel N-cadherin antagonist. Peptides 2008; 29: 1853\u20131861.","journal-title":"Peptides"},{"key":"BFonc2017171_CR72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/15419069709004457","volume":"4","author":"RB Hazan","year":"1997","unstructured":"Hazan RB, Kang L, Whooley BP, Borgen PI . N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 1997; 4: 399\u2013411.","journal-title":"Cell Adhes Commun"},{"key":"BFonc2017171_CR73","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nm.2236","volume":"16","author":"H Tanaka","year":"2010","unstructured":"Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med 2010; 16: 1414\u20131420.","journal-title":"Nat Med"},{"key":"BFonc2017171_CR74","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1515\/hsz-2014-0155","volume":"395","author":"L Bruney","year":"2014","unstructured":"Bruney L, Conley KC, Moss NM, Liu Y, Stack MS . Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16\/CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium. Biol Chem 2014; 395: 1221\u20131231.","journal-title":"Biol Chem"},{"key":"BFonc2017171_CR75","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676\u2013682.","journal-title":"Nat Methods"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017171","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:31:47Z","timestamp":1647894707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":75,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,10,19]]}},"alternative-id":["BFonc2017171"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.171","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"assertion":[{"value":"10 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}